Mastopexy Market To Hit Value .14 Billion By 2030 |Grand View Research, Inc.Posted by Mrudula Anil Karmarkar on September 14th, 2022 The global mastopexy market size is expected to reach USD 2.14 billion by 2030, based on a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 5.7% from 2022 to 2030. Mastopexy is a surgical breast lifting operation that tightens the breasts. Factors such as breast sagging, which happens due to aging or pregnancy, major weight reduction, and breast cancer are responsible for the rising demand for these procedures. The most commonly performed mastopexy procedures are crescent breast lift, Benelli lift, Benelli-lollipop Lift, and full mastopexy. The COVID-19 pandemic posed unique limitations for breast lifting surgeries. Initially, there was a significant decrease in the number of breast augmentation procures as the elective procedures were limited. The mastopexy market was majorly affected however, the market has started recovering gradually. The growing demand for breast appearance in the population encourages the development of better infrastructure to provide better services. Some countries lack the necessary infrastructure and competent professionals to perform aesthetic breast lifting procedures. Hence, there is a scope for market growth, especially in the nations popular for medical tourism. Medical procedures such as cosmetic surgeries encourage people to travel to distant nations in exchange for receiving better treatment at a lower cost. Having surgery performed overseas saves between 40 to 80 percent of the entire cost. The market growth can be attributed to the growing demand for improved aesthetic appearance among women. The key market players have introduced high-tech devices for better surgeries and ultimate customer satisfaction. In addition, the increasing medical tourism in some countries such as Thailand, Malaysia, and Mexico is enhancing the demand for cosmetic breast augmentation surgeries. To Request Sample Copy of this report, click the link: https://www.grandviewresearch.com/industry-analysis/mastopexy-market-report/request/rs1 In the initial phase of the COVID-19 pandemic, the growth of the mastopexy market was affected as there was a significant decrease in elective procedures, especially cosmetic surgeries. The pandemic posed distinctive challenges for breast enhancement or reconstruction surgeries. Many organizations placed restrictions initially on these surgeries, resulting in surgeons and cosmetic clinics conceiving innovative protocols. Although these procedures were halted initially by most cosmetic surgeons, they were resumed in later stages of the pandemic. Mastopexy Market Report Highlights
The growth of the healthcare infrastructure and rising income levels in developing countries such as China, India, and Brazil are contributing to the rising demand for cosmetic breast lifting procedures. A breast lift procedure can be costlier than a breast implant. The cost of breast lifting surgeries ranges between USD 9,000 to USD 16,000. On the other hand, the cost of breast implants ranges from USD 6,000 to USD 12,000. Silicone implants had been utilized in 84% and saline implants in 16% of all the breast augmentations in 2020 (declined 33% from 2022). Considering age as one of the segments in breast lift surgical procedures, it has been noted that around 40% of the total procedure is performed for age 40-54, followed by 27% of total procedure for age 30-39. The breast lift in teenagers has gone down to 23% compared to 2022 (in 2020 the total surgeries performed were 1,006) in the U.S. Breast lift is also performed for those who lose weight suddenly. The number of people who performed mastopexy after sudden weight loss declined 16% from 13,050 in 2022 to 10,972 in 2020. Have a Query? Ask Our Expert: https://www.grandviewresearch.com/inquiry/452786/ibb The Benelli-lollipop lift segment is anticipated to witness the fastest CAGR of 7.2% during the forecast period from 2022 to 2030. It is also known as vertical lift or vertical mastopexy. Vertical incisions are particularly used to remove excess skin horizontally, to the sides of the nipple. This procedure allows the reshaping of areolas. This procedure uses the natural tissue that is already present and reshapes and tightens it to form a more balanced contour. The increasing population concerned about the aesthetic appearance drives the manufacturing of mastopexy devices. Some market players are undertaking strategic initiatives such as mergers and partnerships to strengthen their market presence and expand their product portfolio. For instance, Allergan merged with AbbVie in June 2022 to form Allergan AbbVie. The company's product range includes Acular, Asacol, Betagan, and Alphagan. Allergan's products are manufactured, researched, and utilized commercially in over 100 countries, including India, Australia, Austria, Chile, Brazil, and Germany. Allergan acquired ZELTIQ Aesthetics, a medical device firm, in April 2017. Some prominent players in the global mastopexy market include:
Like it? Share it! More by this author |